190 related articles for article (PubMed ID: 34951563)
1. Depleting circ_0088364 restrained cell growth and motility of human hepatocellular carcinoma via circ_0088364-miR-1270-COL4A1 ceRNA pathway.
Sun K; Wang H; Zhang D; Li Y; Ren L
Cell Cycle; 2022 Feb; 21(3):261-275. PubMed ID: 34951563
[TBL] [Abstract][Full Text] [Related]
2. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
3. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0073181 contributes to tumorigenesis by regulating protein tyrosine phosphatase receptor type E via miR-548p in hepatocellular carcinoma.
Wang Y; Wang H; Jia Y; Wang X; Yang C; Xue T
Anticancer Drugs; 2022 Feb; 33(2):167-177. PubMed ID: 34657099
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis.
Chen Y; Song S; Zhang L; Zhang Y
Clin Transl Oncol; 2021 Nov; 23(11):2280-2292. PubMed ID: 33934291
[TBL] [Abstract][Full Text] [Related]
7. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C
Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275
[TBL] [Abstract][Full Text] [Related]
9. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
Chen Y; Li S; Wei Y; Xu Z; Wu X
Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
[TBL] [Abstract][Full Text] [Related]
10. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ_0003028 regulates cell development through modulating miR-498/ornithine decarboxylase 1 axis in hepatocellular carcinoma.
Zhang T; Sun Q; Shen C; Qian Y
Anticancer Drugs; 2023 Apr; 34(4):507-518. PubMed ID: 36730287
[TBL] [Abstract][Full Text] [Related]
12. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
Fu D; Ji Q; Wang C; Yu L; Yu R
Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
[TBL] [Abstract][Full Text] [Related]
13. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
14. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.
He W; Zhu X; Tang X; Xiang X; Yu J; Sun H
Anticancer Drugs; 2022 Jan; 33(1):e336-e348. PubMed ID: 34419960
[TBL] [Abstract][Full Text] [Related]
15. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
16. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
Liu J; He X; Zou Y; Wang K
Dig Dis Sci; 2022 Jun; 67(6):2269-2282. PubMed ID: 34231101
[TBL] [Abstract][Full Text] [Related]
18. Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner.
Yu F; Fang P; Fang Y; Chen D
Environ Toxicol; 2024 Jun; 39(6):3721-3733. PubMed ID: 38546290
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ_0021093 regulates miR-432/Annexin A2 pathway to promote hepatocellular carcinoma progression.
Wang Y; Xu W; Zu M; Xu H
Anticancer Drugs; 2021 Jun; 32(5):484-495. PubMed ID: 33675609
[TBL] [Abstract][Full Text] [Related]
20. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
